Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

73.95
BATS BZX Real-Time Price
As of 2:11pm ET
 +0.61 / +0.83%
Today’s Change
63.76
Today|||52-Week Range
82.10
+3.27%
Year-to-Date
Pfizer's Ibrance in First-Line Combo Breast Cancer Study
10:44am / Zacks.com - Paid Partner Content
4 Biotech Stocks to Add to your Portfolio Post Q2 Earnings
Aug 22 / Zacks.com - Paid Partner Content
Are Glaxo's Successful New Drugs Enough to Drive Growth?
10:27am / Zacks.com - Paid Partner Content
10 Undervalued Stocks for the Enterprising Investor
Aug 21 / GuruFocus News - Paid Partner Content
Orbimed Advisors Llc Buys Cigna Corp, Clovis Oncology Inc, Gilead Sciences Inc, Sells...
Aug 22 / GuruFocus News - Paid Partner Content
Mylan Finalizes Settlement Agreement with DOJ for $465M
Aug 18 / Zacks.com - Paid Partner Content
Alkermes Initiates Rolling Submission of Depression Drug
Aug 22 / Zacks.com - Paid Partner Content
AbbVie's HCV Combo Drug Mavyret Clinches Approval in Canada
Aug 18 / Zacks.com - Paid Partner Content
Alexion's (ALXN) Soliris' Label Expansion Approved in Europe
Aug 22 / Zacks.com - Paid Partner Content
Gilead (GILD) HCV Drug Vosevi Receives Approval in Canada
Aug 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close73.34
Today’s open73.27
Day’s range73.22 - 73.97
Volume508,553
Average volume (3 months)8,459,917
Market cap$95.8B
Dividend yield2.81%
Data as of 2:11pm ET, 08/23/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-25.07%
Earnings growth (next 5 years)-10.33%
Revenue growth (last year)-5.37%
P/E ratio8.0
Price/Sales3.21
Price/Book5.09

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.14-0.67%
BIIBBiogen-3.72-1.30%
ILMNIllumina Inc-1.60-0.82%
KITEKite Pharma Inc+3.08+2.27%
Data as of 2:11pm ET, 08/23/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$2.11
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts